medicalxpress - A protein best known for driving cancer growth also helps damaged tumor cells survive by repairing their DNA, according to a new study that could influence how some cancers are treated.
AI Summary: New research reveals overactive MYC drives tumor cells to repair DNA breaks more efficiently, enabling resistance to chemotherapy. By illuminating the repair pathways MYC hijacks, the study identifies potential targets to reverse resistance and improve treatment responses — because apparently cancers read the manual on how to survive your best shot.
Rogaratinib shows activity in SDH‑deficient GIST phase 2 trial / 43 hrs
Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity / 2 months
CRISPR CD33‑deleted allogeneic transplant shows early AML promise / 15 days
Single‑cycle pembrolizumab yields striking responses in dMMR colon cancer / 20 days
Teclistamab outperforms standard regimens in earlier-line relapsed myeloma / 46 hrs
Common asthma drug may overcome immunotherapy resistance in cancers / 11 days
Retifanlimab plus chemotherapy extends survival in advanced squamous anal cancer / 13 days
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.